Keywords: innovata, agrees, adept, licensing, deal, nottingham, uk-based
Innovata agrees Adept licensing deal
Article | 09 January 2006
Nottingham, UK-based pharmaceutical development company Innovata says it has granted US firm Baxter International a global license for Adept (icodextrin 4%), ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
